ABL, Inc., a biomedical contract research and manufacturing organization to the biotechnology and pharmaceutical industry, has been selected by Profectus BioSciences, Inc. to evaluate different delivery regimens of one of its HIV vaccine candidates.
http://ift.tt/1hGqgIR
http://ift.tt/1hGqgIR
No comments:
Post a Comment